Roche NimbleGen to Expand CGH Array Menu, Plans Additional High-Density Chips
March 29, 2011
Roche NimbleGen to Expand CGH Array Menu, Plans Additional High-Density Chips
The new high-density chips could give Roche NimbleGen an advantage in the market for clinical research arrays, such as cytogenetics, where it competes against Affymetrix, Agilent Technologies, and Illumina.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Affy Files CytoScan with FDA, Plans 'Aggressive' Marketing Campaign to Grow Cyto Business
February 19, 2013 / BioArray News - After 'Pivotal' 2012, Affy Looks to CytoScan, Axiom Genotyping Products to Drive Future Growth
February 5, 2013 / BioArray News - Cytogeneticists Say Platform Choice a Question of Personal Preference, Circumstance
August 21, 2012 / BioArray News - Affymetrix to Start Clinical Trials for CytoScan HD in March, Plans FDA Submission by Midyear
January 17, 2012 / BioArray News - Agilent to Debut New CGH and SNP Arrays to Support Cyto, Cancer Research
September 14, 2010 / BioArray News